Innovaderma – SELL
By
Azeez Mustapha
PUBLISHED:
08 Nov 2017 @ 21:46
|
Comments (0)
|
More info about Azeez Mustapha
Innovaderma stock (LSE:IDP) is in a downtrend, which has been in place since September 2017. Further downward movement is expected.
The market has gone below the EMA 21, while the Williams’ % Range period 20 is around the oversold region.
Price has gone seriously downwards and it is currently below the resistance level at 280.
While there could be attempted rallies along the way to the south, they are expected to be transitory as price would go further downwards.
The signal on Innovaderma is a SELL one and price may reach the support levels at 200, 175 and 150 within the next several months.
Traders’ Mindset: Traders’ Mindset
CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).
This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Plc. ADVFN Plc does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.